Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
860.3 USD | +1.21% |
|
+3.53% | +47.64% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
12:55pm | Eli Lilly Study Shows Tirzepatide Superior to Placebo | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.64% | 765B | |
-6.35% | 354B | |
+20.24% | 331B | |
+9.45% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.43% | 164B | |
-2.34% | 162B | |
+0.57% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating